Binge drinking reached a historic high for adults aged 35-50 in 2022.

Clinical research indicates the potential for strong mental health applications.

Enacted as part of the state’s budget bill, this new regulation comes with stipulations and exclusions.

The likelihood of long COVID, claims costs, and claim duration all increased with the severity of acute COVID-19.

These funds will help states and communities respond more quickly, effectively, and equitably to prevent overdose death and injury.

Kristine Kennedy discusses attributes of effective technology for managed care programs, Silvia Sacalis examines post-opioid epidemic medical trends, and Sandy Shtab speaks on marijuana.

As other Pfizer plants shift gears to make up for this damage, overall drug manufacturing may slow in some areas.

Helpful tips for addressing injured worker unfamiliarity with workers’ comp.

According to JAMA, only 22% of OUD patients received medication-assisted therapy.

The national trend continues, in this case with qualifying events and the inclusion of 911 dispatchers.

RiVive will soon be available without a prescription for the treatment of known or suspected opioid overdose.

Stop by our educational session or visit our booth for the latest issue of RxInformer magazine.

These guidelines advise researchers on study design and other considerations as they develop medications that contain psychedelics.

How problematic alcohol use can impact the workplace, claims, and medication management.

A new study uses data from 583,000 group health patients with chronic noncancer pain.

Employees who experience a qualifying traumatic event on the job can receive PTSD coverage via workers’ comp.

Jeanette Connelly was named President of the Florida Pharmacy Association, and Silvia Sacalis was featured in a video spotlight by Business Insurance.

A new buprenorphine injection will be available for weekly or monthly dosages, administered by providers.

An infographic breakdown of the diverse drug categories that comprise dermatological prescribing and spend.

A new report from the CWCI highlights trends in dermatologicals, opioids, and antidepressants.

Opvee is a nalmefene hydrochloride nasal spray – a new option available for the reversal of opioid overdose.

Healthe’s VP, Program Performance and Analytics, Cliff James, shares his thoughts on how inflation is impacting these two sectors of care.

Amanda Waltemath has been recognized as a talented young professional making a positive impact in workers’ comp.

Teva is recalling certain lots of fentanyl buccal tablets, while Family Dollar is recalling Advil that was not kept at proper temperature.

Rising prices for healthcare products and services may impact workers' comp medical care.

Changes to boxed warnings, indications and usage, dosage and administration, and more.

Approximately 21% of adults experienced chronic pain in 2021, with greater prevalence among certain demographics.

As other states come closer to recreational legalization, Washington State pushes the needle further.

Healthe’s VP of Clinical Services, Silvia Sacalis, will co-present this educational session at PRIMA 2023.

Patients will no longer need a prescription for this opioid overdose antidote.

A sneak peek into our RISKWORLD 2023 session content focused on cybersecurity strategies in an evolving risk landscape.

How formularies impacted prescriptions across Arkansas, California, Indiana, Kentucky and New York.

Three states have introduced bills or seen court cases overturned in relation to this policy.

Healthe’s VP of Clinical Services, Silvia Sacalis, will co-present this educational session at IRSG 2023.

A new combination of acetaminophen and ibuprofen will soon hit the market.

Psychosocial factors can increase the likelihood of musculoskeletal disorders and substance abuse.

Extended physical medicine was 5-9 times as common in claims with multiple providers.

Beyond PTSD, cancers, heart conditions, and communicable diseases are seeing legislative activity.

Fenoprofen calcium made up 1.4% of NSAID prescriptions, but 33% of NSAID payments.

Tony Brown, Healthe’s Director of Information Security, will speak at the upcoming conference.

Several states have submitted bills to expand presumptions for first responders.

How employment, poverty, housing, and food security impact patient health.

Both the WCRI and the New York State Insurance Fund published new reports.

New reports from the Journal of the American Medical Association and Health Economics.

Over 500 stakeholders share their thoughts on industry challenges, priorities, and technologies.

Sunlenca approved for treatment-resistant populations, but a number of other drugs will cease production, some of which are included in PEP guidelines.

Tobacco use as a complicating factor in workplace injury and recovery.

Exposure to various gases and vapors has been associated with autoimmune disease

Two new studies highlight marijuana’s analgesic effects.

Preliminary findings from Healthe’s 2023 industry survey.

Tzield (teplizumab-mzwv) injections can delay onset by several months or years.

How the timing and accuracy of diagnostic testing can determine the course of a claim.

This vaccine blocks fentanyl from entering the brain and triggering euphoric effect.

This report contains a high level report on the status of the Texas workers’ comp system.

Risk & Insurance^® magazine taps Healthe’s VP of Clinical Services for considerations on retaining a healthy and happy workforce.

First-time generics are available for drugs that treat COPD, HIV, hypertension, and more.

The insurance sector continues to face IT talent shortages – how does this impact workers’ comp organizations?

An update to the 2016 guidelines has been issued, promoting greater flexibility for individualized patient-centered care.

Maryland and Missouri voters pass recreational legalization.

Data insights on medical payments for 18 state workers’ comp systems.